ENDRA Life Sciences (NDRA) Accumulated Depreciation & Amortization (2016 - 2021)
Historic Accumulated Depreciation & Amortization for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to $556637.0.
- ENDRA Life Sciences' Accumulated Depreciation & Amortization rose 1284.36% to $556637.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $556637.0, marking a year-over-year increase of 1284.36%. This contributed to the annual value of $506660.0 for FY2020, which is 1438.88% up from last year.
- According to the latest figures from Q3 2021, ENDRA Life Sciences' Accumulated Depreciation & Amortization is $556637.0, which was up 1284.36% from $526814.0 recorded in Q2 2021.
- ENDRA Life Sciences' 5-year Accumulated Depreciation & Amortization high stood at $556637.0 for Q3 2021, and its period low was $291840.0 during Q1 2017.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $442928.0 (2019), whereas its average is $423421.4.
- Per our database at Business Quant, ENDRA Life Sciences' Accumulated Depreciation & Amortization skyrocketed by 2226.33% in 2017 and then soared by 512.81% in 2020.
- ENDRA Life Sciences' Accumulated Depreciation & Amortization (Quarter) stood at $337630.0 in 2017, then increased by 20.23% to $405946.0 in 2018, then grew by 9.11% to $442928.0 in 2019, then grew by 14.39% to $506660.0 in 2020, then grew by 9.86% to $556637.0 in 2021.
- Its Accumulated Depreciation & Amortization stands at $556637.0 for Q3 2021, versus $526814.0 for Q2 2021 and $493085.0 for Q1 2021.